BBIO · US market

Bridgebio Pharma Inc

Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.

Market cap US$13.08bnFinancials dated 30 June 2026Price dated 1 October 2026

Core valuation

Trailing P/E-18.91×
Latest-quarter run-rate P/E-21.48×
Trailing P/S18.34×
Latest-quarter run-rate P/S13.42×

Calculation inputs

Trailing earnings
-US$691.87m
Latest-quarter run-rate earnings
-US$608.86m
Latest fiscal-year earnings
-US$724.93m
Trailing revenue
US$713.07m
Latest-quarter run-rate revenue
US$974.70m
Latest fiscal-year revenue
US$502.08m

Featured ETF and mutual-fund exposure

These public funds report this company in their latest disclosed holdings.

  • HELX · Franklin Genomic Advancements ETF3.50% weight · Holdings dated 30 June 2026
  • MCGIX · AMG GW&K Small Cap Growth Fund - Class I1.74% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • SSCGX · SEI Institutional Managed Trust Small Cap Growth Fund Class F1.59% weight · Holdings dated 30 June 2026
  • PSMLX · Principal SmallCap Fund Class R61.52% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • DCZRX · Nomura Small Cap Core Fund Class R61.35% weight · Holdings dated 29 May 2026
  • FSML · Franklin Small Cap Enhanced ETF1.32% weight · Holdings dated 30 June 2026
  • LMOIX · ClearBridge Small Cap Growth Fund Class IS1.28% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • ANOAX · American Century Small Cap Growth Fund A Class1.16% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • ACWIX · AMG GW&K Small/Mid Cap Growth Fund - I1.15% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • QUAZX · AB Small Cap Growth Portfolio Class Z1.15% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.

Sources and limitations

Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.

Open financial source

Financials as of 30 June 2026. Informational research, not investment advice.